Artificial Tear: Clinical Trials

14 trials of Artificial Tear, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 5 Not applicable, 5 Phase 4, 2 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 5
Phase 45Completed 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 22Completed 1, Not yet recruiting 1
Phase 32Completed 1, Unknown 1
Phase 11Completed 1

Follow Artificial Tear: new trials by email Literature Review of Artificial Tear trials Research Report on Artificial Tear

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
BRM421 Ophthalmic Solution, 0.03%, Artificial Tear, BRM421 Ophthalmic Solution, 0.06% - Dry Eye Disease (DED), Keratoconjunctivitis Sicca
Phase 2Not yet recruitingBRIM Biotechnology Inc.992025-12-012025-10-20
Topical Insulin for Ocular Surface Interface in Dry Eye Disease
Artificial tear, insulin human - Dry Eye, Insulin Sensitivity
Phase 4CompletedKhyber Teaching Hospital1282025-04-142026-08-14
Tear Film Markers in Dry Eye Syndrome
Cyclosporine, Artificial tear - Dry Eye
Phase 4WithdrawnVishal Jhanji2023-12-082023-12-18
Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
Insulin, Artificial tear - Dry Eye, Glaucoma
Phase 4RecruitingBarbara Burgos Blasco1002023-02-082024-10-22
Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level
Vitamin D, Artificial tear - Dry Eye Syndromes, Hypovitaminosis D
Phase 3CompletedUniversity of Faisalabad1082021-11-012022-06-21
Acupoint Therapy Device for Dry Eye
dry eye acupoint therapy instrument, Artificial tear - Dry Eye
Not applicableCompletedShanghai 10th People's Hospital1202021-01-012024-12-06
Influence of Artificial Tears on Keratometry and Biometry Measurements With Different Devices
Artificial tear, No artificial tears - Healthy
Not applicableCompletedUniversity Clinic Frankfurt1452020-11-202024-04-10
Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate
Atropine (0.01%), Artificial tear - Myopia
Not applicableCompletedThe Hong Kong Polytechnic University712018-02-012024-10-16
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
Nepafenac 0.1% Oph Susp, Nepafenac 0.3% Oph Susp, Artificial tear - Pain
Not applicableCompletedUniversity Hospital of Patras992017-09-012018-04-04
Effects of Dry Eye Treatments on the Ocular Surface
Dexamethasone, Artificial tear - Keratoconjunctivitis Sicca, Dry Eye Syndrome
Phase 4CompletedBaylor College of Medicine202013-02-012020-02-05
Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
Ganciclovir, Artificial tear - Conjunctivitis, Viral, Adenoviridae Infections
Not applicableCompletedFederal University of São Paulo332009-08-012011-05-06
Topical IL-1-Ra for Treatment of Posterior Blepharitis
2.5% IL-1Ra, Placebo, 5% IL-1Ra - Posterior Blepharitis
Phase 1 / Phase 2CompletedReza Dana, MD752008-01-012018-01-19
Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
neomycin sulfate, polymyxin B sulfate and gramicidin, Artificial tear - Hordeolum
Phase 3UnknownChulalongkorn University1202007-09-012010-11-23
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
Cyclosporine A 0.05%, Arificial Tear - Dry Eye
Phase 4TerminatedMassachusetts Eye and Ear Infirmary82007-08-012017-03-28

Conditions studied

Dry Eye Syndromes (8)  ·  Keratoconjunctivitis Sicca (2)  ·  Adenoviridae Infections (1)  ·  Conjunctivitis, Viral (1)  ·  Glaucoma (1)  ·  Graft vs Host Disease (1)  ·  Hordeolum (1)  ·  Insulin Resistance (1)  ·  Meibomian Gland Dysfunction (1)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)  ·  Myopia (1)  ·  Pain (1)  ·  Vitamin D Deficiency (1)

Sponsors

BRIM Biotechnology Inc. (1)  ·  Barbara Burgos Blasco (1)  ·  Baylor College of Medicine (1)  ·  Chulalongkorn University (1)  ·  Federal University of São Paulo (1)  ·  Khyber Teaching Hospital (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Reza Dana, MD (1)  ·  Shanghai 10th People's Hospital (1)  ·  The Hong Kong Polytechnic University (1)  ·  University Clinic Frankfurt (1)  ·  University Hospital of Patras (1)  ·  University of Faisalabad (1)  ·  Vishal Jhanji (1)

Countries

United States (3)  ·  Pakistan (2)  ·  Brazil (1)  ·  China (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Barbara Burgos Blasco, MD, PhD (1)  ·  Bushra Kanwal, MPO (1)  ·  Constantine Georgakopoulos, MD, PhD (1)  ·  Parima Hirunwiwatkul, MD (1)  ·  Reza Dana, M.D. (1)  ·  Reza Dana, MD, MPH, MSc (1)  ·  Shafiq Tanvee, MBBS, FCPS (1)  ·  Simone T Yabiku, MD (1)  ·  Stephen Pflugfelder, MD (1)  ·  Vishal Jhanji, MD (1)

Results publications

PMID 22331114, PMID 23599118, PMID 30802601